Investor FAQ
When was Taro established?
What is Taro's corporate address?
14 Hakitor Street
Haifa Bay 2624761 Israel
What are the addresses of your major facilities?
Taro Pharmaceutical Industries Ltd. (Taro Israel)
14 Hakitor Street
Haifa Bay 2624761 Israel
Taro Pharmaceuticals U.S.A., Inc. (Taro USA)
3 Skyline Drive
Hawthorne, NY 10532 USA
Taro Pharmaceuticals, Inc. (Taro Canada)
130 East Drive
Brampton, Ontario L6T 1C1, Canada
Where are Taro’s shares listed?
How can I purchase shares of Taro stock?
Who is Taro’s transfer agent?
New York, NY USA
www.astfinancial.com
(800) 937-5449 or (718) 921-8124
What can the transfer agent help me with?
- Lost stock certificates
- Clarification of number of shares owned
- Transfer of certificates between individuals
- Transfer of certificates to/from broker
- Address changes
- Other stock related matters
Does Taro pay a dividend?
Where can I find historical prices for Taro’s common stock?
How can I receive a hard copy of Taro's complete audited financial statements?
Taro provides all shareholders, upon request, with a hard copy of our complete audited financial statements on Form 20-F- free of charge. Investor Relations Contact
The Annual Report on Form 20-F is also available on Taro’s website. (Click here)
How can I receive investor materials as they are issued?
How do I contact Taro Investor Relations?
3 Skyline Drive
Hawthorne, NY 10532
Phone: (914) 345 9001
investorrelations@taro.com
How can I receive a copy of your product list?
- Use the online product list for the country you're interested in, then click on "Taro Products"
- Call 1-888-TARO-USA
- Write to us, c/o Taro Pharmaceuticals U.S.A., Inc., 3 Skyline Drive, Hawthorne, NY 10532, Attn: Marketing, Product list-Request
What percentage of Taro does Sun Pharmaceuticals own?
Who do you consider as major competitors in your major markets?
In Israel, we compete with Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexcel Pharma Israel, and Rafa Laboratories Ltd., among others. In addition, many leading multinational companies, including Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc., market their products in Israel.
In the United States, we compete with branded pharmaceutical manufacturers such as Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc. and Galderma Laboratories, LP., as well as with generic companies such as Teva Pharmaceuticals U.S.A., Mylan Inc., Perrigo Company PLC, Glenmark Generics, Inc., USA., PruGen Inc. and Sandoz Pharmaceuticals (the generics subsidiary of Novartis).
In Canada, our competition includes Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Valeant Canada, AstraZeneca Canada, Johnson & Johnson Inc., Bayer Inc. and Bristol-Myers Squibb Canada. We also compete with other manufacturers of generic products, such as Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated and Pharmascience Inc.